| All | AHI < 15 | 15 ≤ AHI < 30 | AHI > 30 | p value |
---|---|---|---|---|---|
n | 126 | 39 | 27 | 60 | – |
Age, years | 59.3 (9.5) | 59.6 (10.6) | 61.4 (10.4) | 58.1 (8.3) | 0.33 |
Women, % | 40.3 | 51.3 | 36.0 | 35.0 | 0.24 |
BMI, kg/m2 | 33.2 (6.3) | 32.0 (6.4) | 32.5 (6.2) | 34.4 (6.1) | 0.14 |
Waist circumference, cm | 113.0 (17.0) | 108.0 (18.9) | 115.2 (16.6) | 115.3 (15.9) | 0.22 |
Waist-to-hip ratio | 1.2 (0.4) | 1.1 (0.3) | 1.3 (0.4) | 1.3 (0.5) | 0.19 |
Current smokers, % | 13.5 | 18.8 | 14.3 | 7.1 | 0.42 |
Hypertension, % | 59.0 | 46.2 | 66.7 | 64.4 | 0.14 |
Duration of diabetes, years | 9.0 (7.7) | 10.1 (7.4) | 10.4 (8.7) | 7.7 (7.3) | 0.20 |
Metformin, % | 90.3 | 87.1 | 94.7 | 90.7 | 0.83 |
Sulfonylurea, % | 26.7 | 24.0 | 27.8 | 27.9 | 0.93 |
DPP-4 inhibitors, % | 19.8 | 25.0 | 16.7 | 17.5 | 0.70 |
Injectable GLP-1 analog, % | 9.6 | 3.7 | 0.0 | 18.0 | 0.01 |
Insulin, % | 13.1 | 10.3 | 29.2 | 8.5 | 0.03 |
Antihypertensive medications | |||||
 ACE inhibitors, % | 32.9 | 28.6 | 25.0 | 39.0 | 0.50 |
 CCBs, % | 17.1 | 7.7 | 6.3 | 27.5 | 0.05 |
 β-blockers, % | 23.2 | 32.1 | 16.7 | 20.0 | 0.38 |
 Cholesterol-lowering drugs, % | 61.4 | 56.7 | 58.8 | 65.9 | 0.71 |
 Antiaggregants, % | 14.5 | 18.5 | 11.8 | 12.8 | 0.76 |
Sleep-disordered breathing indices | |||||
 AHI, n | 33.7 (27.5) | 7.1 (4.3) | 21.9 (4.0) | 56.2 (23.3) | <0.0001 |
 ODI, n | 34.2 (45.7) | 10.7 (17.9) | 21.7 (16.6) | 54.8 (56.3) | <0.0001 |
 T90, % | 54.0 (75.8) | 30.8 (58.1) | 35.2 (32.0) | 77.9 (92.2) | <0.0001 |
 TDS, min. | 55.2 (17.6) | 52.0 (16.5) | 53.4 (10.2) | 58.1 (20.4) | 0.22 |